“Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies” (2022) Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022060. doi:10.4084/MJHID.2022.060.